Sun Pharmaceuticals Industries Limited 2.08 % Biotechnology

Trend Analysis

Loading...

Support and Resistance Levels Analysis
The current close value 453.0 is between the support and resistance channel of 435 and 468. The stock has a Sell Signal , 435 becomes a critical support to stop the fall and 468 is a immediate resistance on the upside.

Technical Indicators (3 Month duration)
Exponential Moving average 460.4
MACD value -13.3
Price range 443.75 to 569.65
Volume range 2772764 to 11015468
Support & Resistance 435, 468
Stock Performance
Six Months -13.4%
Five Months-20.8%
Four Months-23.5%
Three Months-16.9%
Two Months-10.3%
One Month-12.5%
Last Six Months

-13.4%

Last Five Months

-20.8%

Last Four Months

-23.5%

Last Three Months

-16.9%

Last Two Months

-10.3%

Last One Month

-12.5%

Analysis
Volume
Today's Price Range
3 Month Price Range
About Sun Pharmaceuticals Industries Limited
Sun Pharmaceutical Industries Ltd. (Sun) is a specialty pharmaceutical company. The Company manufactures and markets a range of pharmaceutical formulations as branded generics, as well as generics, in the United States, India and other markets. It operates through four segments: US Generics, Indian Branded Generics, International Branded Generics (rest of the world, except the United States) and Active Pharmaceutical Ingredients (API). Sun manufactures specialty APIs, including peptides, steroids, hormones and anticancers. The Company's API products include Acamprosate Calcium, Alendronate Sodium, Bortezomib, Cisplatin, Choline Fenofibrate and Carvedilol. It offers products across five continents in over 150 nations with a presence in the United States, India, Asia, Europe, South Africa, Commonwealth of Independent States and Russia, and Latin America. It also offers specialty and generic products across a range of chronic and acute prescription drugs.
See stocks similar to Sun Pharmaceuticals Industries Limited in Biotechnology

Sun Pharmaceuticals Industries Limited has Sell Signal. What is your opinion on it?

{ }